Quarters are matched automatically on the comparison year: pick once, both periods stay aligned.
| Line item | FY2026 (Q2) | FY2025 (Q2) |
|---|---|---|
| Revenue | $789.61M | $745.34M |
| COGS | $241.44M | $248.77M |
| Gross Profit | $548.17M | $496.58M |
| R&D | $36.32M | $39.95M |
| SG&A | $286.82M | $303.62M |
| D&A | $0 | $70.63M |
| Amortization Of Intangibles | — |
QuarterCharts · SEC EDGAR data · GMED · Comparing FY2026 (Q2) vs FY2025 (Q2)
| $30.19M |
| Other D&A (derived) | — | $40.44M |
| Other OpEx | $42.6M | $6.26M |
| Acquisition Related Costs | $11.08M | — |
| Other OpEx (derived) | $31.52M | — |
| Operating Income | $182.43M | $76.11M |
| Interest Exp. | $7.07M | $693K |
| Other Non-Op | $0 | $0 |
| Non-Op Income | $14.46M | $112.76M |
| Pretax Income | $189.82M | $188.17M |
| Tax | $38.25M | $0 |
| Other (Below Tax) | $0 | $0 |
| Other Income (After Tax) | $0 | $0 |
| Tax Benefit | $0 | $14.67M |
| Net Income | $151.57M | $202.85M |
